Evidence map›Paper›PMID 40302843›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2025

Optimizing outcomes in heart transplantation: multidisciplinary Heart Teams and mechanical circulatory support for primary graft dysfunction.

Assad Haneya, Pia Lanmüller, Bernd Panholzer, Wiebke Sommer, Wiktor Kuliczkowski, Mateusz Sokolski, Roman Przybylski, Bastian Schmack, Sadeq Ali-Hasan-Al-Saegh, Sho Takemoto and 2 more

Erratum issuedAbstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Assad HaneyaDepartment of Cardiothoracic Surgery, Heart Centre Trier, Barmherzigen Brueder Hospital, Nordallee 1, Trier 54292, Germany.
Pia LanmüllerDepartment of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité, Augustenburger Platz 1, Berlin 13353, Germany.
Bernd PanholzerDepartment for Cardiac Surgery, UKSH Campus Kiel, Arnold-Heller-Straße 3, Haus C, Kiel 24105, Germany.ORCID https://orcid.org/0000-0002-4992-818X
Wiebke SommerDepartment for Cardiac Surgery, UKSH Campus Kiel, Arnold-Heller-Straße 3, Haus C, Kiel 24105, Germany.
Wiktor KuliczkowskiInstitute for Heart Diseases, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.
Mateusz SokolskiFaculty of Medicine, Institute of Heart Diseases, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.
Roman PrzybylskiCardiochirurgy and Transplantology, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.
Bastian SchmackDepartment of Cardiothoracic Transplant and Vascular Surgery, Hannover Medical School, Carl-Neuberg-Straße 1, Hannover 30625, Germany.
Sadeq Ali-Hasan-Al-SaeghDepartment of Cardiothoracic Transplant and Vascular Surgery, Hannover Medical School, Carl-Neuberg-Straße 1, Hannover 30625, Germany.
Sho TakemotoCenter for Transplantation Sciences, Massachusetts General Hospital/Harvard Medical School, 13th Street, Building 149, Charlestown, MA 02129, USA.
Rachad ZayatDepartment of Cardiothoracic Surgery, Heart Centre Trier, Barmherzigen Brueder Hospital, Nordallee 1, Trier 54292, Germany.
Nikos WernerHeart Centre Trier, Barmherzigen Brueder Hospital, Internal Medicine III/Cardiology, Nordallee 1, Trier 54292, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart transplantation (HTx) is a definitive treatment for selected patients with advanced heart failure. However, primary graft dysfunction (PGD), a severe early complication, is a major cause of post-HTx morbidity and mortality. This paper explores the pathophysiology, diagnostic approaches, and management strategies for PGD, with a particular focus on temporary mechanical circulatory support (MCS) devices such as venoarterial extracorporeal membrane oxygenation and Impella. It also highlights the essential role of the multidisciplinary Heart Team in optimizing outcomes through patient-tailored MCS selection and timely intervention.

Indexed as

Advanced heart failureHeart TeamHeart transplantationMechanical circulatory supportMultidisciplinary carePrimary graft dysfunction

Identifiers

PMID40302843
PMCPMC12036520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.